HKD 0.05
(-5.45%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -129.53 Million | 55.53 Million | -57.41 Million | 314.12 Million | 4.14 Million | -57.68 Million |
Net Income | -366.22 Million | -420.73 Million | -968.23 Million | -373.72 Million | -2.18 Billion | -1.38 Billion |
Depreciation & Amortization | 64.09 Million | 67.96 Million | 76.33 Million | 123.71 Million | 154.6 Million | 101.45 Million |
Deferred income taxes | - | - | - | -247.88 Million | - | - |
Stock-based compensation | - | - | - | 4.36 Million | - | - |
Change in working capital | -280.8 Million | -24.96 Million | 53.67 Million | 243.52 Million | -128.09 Million | -119.12 Million |
Other non-cash items | 143.65 Million | 433.27 Million | 780.8 Million | 564.14 Million | 2.16 Billion | 1.34 Billion |
Investing Cash Flow | -46.14 Million | 99.21 Million | 140.94 Million | 69.85 Million | 1.12 Billion | -499.38 Million |
Investments in PPE | -40.66 Million | -49.59 Million | -16.28 Million | -104.92 Million | -160.53 Million | -115.53 Million |
Acquisitions | 270 Thousand | 3.44 Million | 1.68 Million | -62.59 Million | 332.36 Million | 7.47 Million |
Investment purchases | -110.96 Million | -19.7 Million | -30.44 Million | -2.18 Million | -68.19 Million | -44.53 Million |
Sales/Maturities of investments | 130.56 Million | 94.27 Million | 73.96 Million | 198.98 Million | 779.41 Million | 37.06 Million |
Other Investing Activities | 4.35 Million | 70.79 Million | 112.03 Million | 40.58 Million | 237.57 Million | -383.84 Million |
Financing Cash Flow | 185 Million | -224.71 Million | -80.56 Million | -408.09 Million | -1.2 Billion | 148.59 Million |
Debt repayment | -223.02 Million | -749.5 Million | -720.7 Million | -465.03 Million | -3.77 Billion | -891.99 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 51.43 Million | - | - | 16.75 Million |
Other Financing Activities | -30.04 Million | 524.78 Million | 588.7 Million | 56.94 Million | 2.56 Billion | 1.02 Billion |
Accounts receivables | -367.5 Million | 57.21 Million | 28.07 Million | 152.93 Million | -70.97 Million | -210.45 Million |
Accounts payables | - | 56.94 Million | -29.19 Million | -246.3 Million | -476.89 Million | - |
Inventory | -4.61 Million | -82.17 Million | 25.59 Million | 90.58 Million | -57.11 Million | 91.33 Million |
Other working capital | -16.02 Million | -56.94 Million | 29.19 Million | 246.3 Million | 476.89 Million | -150.16 Million |
Cash at beginning of period | 161.36 Million | 228.09 Million | 226.05 Million | 251.16 Million | 320.29 Million | 694.44 Million |
Cash at end of period | 171.61 Million | 161.36 Million | 228.09 Million | 226.05 Million | 251.16 Million | 320.29 Million |
Capital Expenditure | -40.66 Million | -49.59 Million | -16.28 Million | -104.92 Million | -160.53 Million | -115.53 Million |
Effect of forex changes on cash | 921 Thousand | 3.22 Million | -925 Thousand | -990 Thousand | 10.74 Million | 34.32 Million |
Net cash flow / Change in cash | 10.24 Million | -66.73 Million | 2.03 Million | -25.1 Million | -69.12 Million | -374.15 Million |
Free Cash Flow | -170.19 Million | 5.94 Million | -73.7 Million | 209.2 Million | -156.38 Million | -173.21 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -222.02 Million | -152.95 Million | -366.22 Million | -194.22 Million | -420.73 Million | -124.12 Million |
Depreciation & Amortization | 34.61 Million | 32.41 Million | 64.09 Million | 31.67 Million | 67.96 Million | 42.83 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -388.13 Million | -280.8 Million | - | -24.96 Million | -81.9 Million |
Other non-cash items | 110.78 Million | 447.07 Million | 143.65 Million | 94.61 Million | 433.27 Million | 201 Million |
Investing Cash Flow | -24.97 Million | -8.9 Million | -46.14 Million | -37.23 Million | 99.21 Million | 60.04 Million |
Investments in PPE | -40.59 Million | -14.04 Million | -40.66 Million | -23.79 Million | -49.59 Million | -26.69 Million |
Acquisitions | - | - | 270 Thousand | - | 3.44 Million | - |
Investment purchases | - | - | -110.96 Million | - | -19.7 Million | - |
Sales/Maturities of investments | - | - | 130.56 Million | - | 94.27 Million | - |
Other Investing Activities | 15.62 Million | 5.14 Million | 4.35 Million | -13.44 Million | 70.79 Million | 86.73 Million |
Financing Cash Flow | 32.17 Million | 135.15 Million | 185 Million | 49.85 Million | -224.71 Million | -101.03 Million |
Debt repayment | -46.38 Million | - | -223.02 Million | -64.79 Million | -749.5 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -14.2 Million | 135.15 Million | -30.04 Million | -14.94 Million | 524.78 Million | -101.03 Million |
Accounts receivables | - | -367.5 Million | -367.5 Million | - | 57.21 Million | 57.21 Million |
Accounts payables | - | - | - | - | 56.94 Million | - |
Inventory | - | -4.61 Million | -4.61 Million | - | -82.17 Million | -82.17 Million |
Other working capital | - | -16.02 Million | -16.02 Million | - | -56.94 Million | -56.94 Million |
Cash at beginning of period | 171.61 Million | 107.18 Million | 161.36 Million | 161.36 Million | 228.09 Million | 164.86 Million |
Cash at end of period | 102.32 Million | 107.18 Million | 171.61 Million | 107.18 Million | 161.36 Million | 161.36 Million |
Capital Expenditure | -40.59 Million | -14.04 Million | -40.66 Million | -23.79 Million | -49.59 Million | -26.69 Million |
Effect of forex changes on cash | 134 Thousand | -220 Thousand | 921 Thousand | 1.14 Million | 3.22 Million | -309 Thousand |
Net cash flow / Change in cash | -69.28 Million | - | 10.24 Million | -54.18 Million | -66.73 Million | -3.5 Million |
Free Cash Flow | -117.22 Million | -75.64 Million | -170.19 Million | -91.73 Million | 5.94 Million | 11.1 Million |
6886
PNCINFRA
WINMED
603050
IPCM
MDM